These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 6762480)

  • 41. [The renaissance of theophylline therapy].
    Ahrens J
    Fortschr Med; 1982 Jun; 100(23):1120-4. PubMed ID: 6286438
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The comparative efficacy of the prolonged-action theophylline preparations Theopek and Euphylong in elderly patients with chronic obstructive lung diseases].
    Salikova VV; Nonikov VE; Belousov IuB
    Ter Arkh; 1993; 65(8):41-4. PubMed ID: 8211801
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Theopek in the treatment of patients with obstructive diseases of the respiratory organs].
    Korzh OB; Vygovskiĭ VP; Stadnicheko RA; Borzhievskaia OE; Kopel'man EI; Kozak KM; Senyk RV; Vygovskiĭ IaV
    Vrach Delo; 1990 Jan; (1):41-2. PubMed ID: 2330707
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The combined effect of theophylline and terbutaline in patients with chronic obstructive airway diseases.
    Lamont H; van der Straeten M; Pauwels R; Moerman E; Bogaert M
    Eur J Respir Dis; 1982 Jan; 63(1):13-22. PubMed ID: 7040097
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Biological availability of two theophylline preparations (author's transl)].
    Kaik G
    Prax Klin Pneumol; 1982 Jun; 36(6):294-6. PubMed ID: 7111181
    [No Abstract]   [Full Text] [Related]  

  • 46. [Double-blind crossover study on the long-term effects of aminophylline retard tablets on the use of salbutamol aerosol spray].
    Brändli O; Langloh P
    Schweiz Rundsch Med Prax; 1982 Oct; 71(40):1553-8. PubMed ID: 6757909
    [No Abstract]   [Full Text] [Related]  

  • 47. [Is there a renaissance of oral theophylline therapy in chronic obstructive airway syndrome?].
    Fenner HG
    ZFA (Stuttgart); 1981 Jul; 57(21):1480-4. PubMed ID: 7281936
    [No Abstract]   [Full Text] [Related]  

  • 48. Pharmacokinetics and pharmacodynamics of a short- and long-acting theophylline medication (Theolair and Theolair retard) in normals and asthmatics. Part II: Lung function and side effects.
    Utama I; Kreukniet J; Fokkens J; Serra R
    Int J Clin Pharmacol Ther Toxicol; 1983 Jun; 21(6):292-6. PubMed ID: 6885203
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Problems on cortison therapy of obstructive pulmonary diseases (author's transl)].
    Christ R
    Z Erkr Atmungsorgane; 1979 Mar; 152(3):263-70. PubMed ID: 494695
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Clinico-pharmacologic aspects of prescribing theophylline-containing preparations].
    Staib AH; Rietbrock N
    Prax Klin Pneumol; 1985 Aug; 39(8):276-80. PubMed ID: 4034490
    [No Abstract]   [Full Text] [Related]  

  • 51. [Effects of theophylline on lung function and sleep in patients with severe chronic obstructive pulmonary disease].
    Li Y; Liu Y
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Oct; 20(5):294-8. PubMed ID: 10374456
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A delayed-release theophylline-noscapine formulation for the relief of airways obstruction.
    Darke CS; Picton EA
    Practitioner; 1970 Feb; 204(220):276-81. PubMed ID: 4906766
    [No Abstract]   [Full Text] [Related]  

  • 53. [Postoperative respiratory therapy: bronchospasmolytic activity and side-effects of some recently introduced beta-sympatheticomimetic agents (author's transl)].
    Brandl M; Beer S; Hamer P
    Anasth Intensivther Notfallmed; 1981 Aug; 16(4):197-202. PubMed ID: 7027819
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Theopek absorption efficiency in chronic diseases of the large intestine].
    Kukes VG; Fazylov AV; Kirkin BV; Kurapov AP; Volchenok VI
    Eksp Klin Farmakol; 1993; 56(4):46-7. PubMed ID: 8220017
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasma theophylline concentrations in patients with chronic obstructive airways disease after administration of a new sustained release theophylline formulation.
    Taylor DR; Kinney CD; McDevitt DG
    Br J Clin Pharmacol; 1982 Apr; 13(4):569-71. PubMed ID: 7066172
    [No Abstract]   [Full Text] [Related]  

  • 56. Theophylline-mexiletine interaction: a case report.
    Kendall JD; Chrymko MM; Cooper BE
    Pharmacotherapy; 1992; 12(5):416-8. PubMed ID: 1437703
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The grade of dyspnea in patients treated with a theophylline derivative (bamifylline) vs controlled-absorption theophylline].
    Giosuè S; Parola D; Cafaggi R; Astengo D; Greco G; D'Onofrio V
    Clin Ter; 1987 Dec; 123(6):457-63. PubMed ID: 2972503
    [No Abstract]   [Full Text] [Related]  

  • 58. [The value of theophylline therapy in the treatment of obstructive respiratory tract diseases].
    Kublik A; von Wichert P
    Internist (Berl); 1988 Nov; 29(11):727-33. PubMed ID: 3069786
    [No Abstract]   [Full Text] [Related]  

  • 59. What use is steady-state theophylline in severe chronic obstructive pulmonary disease? A preliminary report.
    Addis GJ
    Postgrad Med J; 1991; 67 Suppl 4():S34-5; discussion S36. PubMed ID: 1758833
    [No Abstract]   [Full Text] [Related]  

  • 60. [Serum theophylline levels in chronic obstructive pulmonary disease patients receiving uniphyllin].
    Chang SC; Perng RP
    Zhonghua Yi Xue Za Zhi (Taipei); 1988 Jan; 41(1):37-42. PubMed ID: 3167647
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.